abrdn Healthcare Opportunities Fund insiders have been one-way buyers this past year: one person put roughly $11,000 into the stock and nobody sold on the open market.
Biggest single buyer: Mahai Chris LaVictoire, Director, with roughly $11,000.
Big money check: 97 institutions held THQ as of Q2 2026, and more funds bought than sold. Last full quarter: net buying by insiders. Insiders bought in 1 of the last 7 full quarters.
| Filed | Insider | Role | Type | Shares | Price | Value | Source |
|---|---|---|---|---|---|---|---|
| Jul 20, 2026 | Mahai Chris LaVictoire | Director | Buy | 568 | $18.49 | $11K | SEC |
| Jul 18, 2024 | DiMartino Rose | Director | Buy | 1,000 | $21.30 | $21K | SEC |
| Apr 12, 2024 | Goetz Kathleen | Director | Buy | 600 | $19.54 | $12K | SEC |
| Jan 4, 2024 | Reit Todd | Director | Buy | 1,000 | $18.44 | $18K | SEC |
| Jan 2, 2024 | Maher Bill | Director | Buy | 1,000 | $18.25 | $18K | SEC |
In the last 12 months abrdn Healthcare Opportunities Fund insiders made open-market purchases worth about $11,000 and sales worth about $0. Data comes from SEC Form 4 filings, updated every 30 minutes on CapitalSnitch.
The most recent open-market insider trade in THQ was filed on 2026-07-20.
97 investment managers reported holding THQ in SEC Form 13F filings for Q2 2026.
No congressional trades in THQ were reported in the past two years. The full list is free on CapitalSnitch.
Public-record data for research and education, not investment advice. Insider sales are often pre-planned (10b5-1). Congress data: Data derived from public disclosures filed under the Ethics in Government Act and the STOCK Act, republished free for public transparency and news reporting. Disclosures may lag the trade by 45 days or more and show amounts only as ranges. This data may not be used for credit rating, loan underwriting, solicitation of money (political, charitable or other), direct-mail or commercial targeting (5 U.S.C. 13107).